Some peptides used as laboratory reference materials are described in the literature as acting at more than one receptor. Retatrutide, for example, is reported as an agonist at three receptor families: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon. This article summarises the receptor families themselves as a reference for laboratories designing in-vitro receptor studies.
The three receptor families
GLP-1 receptor
A class B G-protein coupled receptor. In the literature it is described as being expressed in pancreatic tissue, the gastrointestinal tract and several regions of the central nervous system. Its signalling behaviour has been characterised extensively in recombinant cell systems, which makes it a common positive control target in receptor assays.
GIP receptor
Also a class B G-protein coupled receptor, and closely related to the GLP-1 receptor in structure. The two receptors share a substantial degree of sequence homology in their extracellular domains, which is one reason why selectivity between them is a recurring theme in ligand characterisation work.
Glucagon receptor
The third class B receptor in this group. It is structurally related to the other two but differs in the distribution and regulation of its expression. Compounds described as acting at all three receptors are sometimes referred to in the literature as triple agonists.
Signalling pathways
All three receptors couple primarily to Gs, and their activation typically raises intracellular cyclic AMP through adenylyl cyclase. Downstream of that, common readouts include protein kinase A activation and cAMP response element driven reporter expression. Receptor desensitisation and internalisation following prolonged agonist exposure are also widely described, and are relevant when designing time-course experiments.
Approaches used to study receptor activity in vitro
- Receptor-binding assays — competition against a radiolabelled or fluorescently labelled reference ligand, giving affinity estimates for the compound under study.
- cAMP accumulation assays — direct measurement of the primary downstream second messenger.
- Reporter gene assays — engineered cell lines in which receptor activation drives a measurable reporter.
- β-arrestin recruitment assays — used to examine signalling bias between pathways.
- Selectivity panels — parallel screening against related receptors to establish receptor preference rather than single-target activity.
Reference material considerations
When a peptide is used as a reference standard in the assays above, the usability of the resulting data depends heavily on how the material is characterised. Three factors recur in practice:
- Purity profile — the measured purity and the profile of related impurities under the stated analytical method.
- Counter-ion and water content — both affect the actual peptide content of a weighed portion, and therefore affect potency calculations.
- Batch documentation — a batch-specific Certificate of Analysis allows a result to be traced back to a defined material.
Experimental design notes
Because these receptors share structural features, assay conditions influence the selectivity that is observed. Receptor density in a recombinant cell line, incubation time, and the choice of reference ligand can each change the apparent result. Reporting the full assay context alongside potency figures is therefore standard practice when comparing data between laboratories.
Material supplied for this type of work is provided strictly as a laboratory reference reagent. No biological or clinical outcome is stated or implied, and no guidance is provided on any use outside controlled laboratory research.